Extension Study of Pimavanserin in Adult Subjects With Neuropsychiatric Symptoms Related to Neurodegenerative Disease

NCT03623321 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

595

Enrollment

INDUSTRY

Sponsor class

Conditions

Neuropsychiatric Symptoms Related to Neurodegenerative Disease

Interventions

DRUG: Pimavanserin

Sponsor

ACADIA Pharmaceuticals Inc.